Edgardo S. Santos: PCR after neoadjuvant is still not enough for cure

Edgardo S. Santos, Vice President of Florida Society of Clinical Oncology and Medical Director of Broward County of Florida at The Oncology Institute of Hope and Innovation, shared a post on X:

”What have I learned after a great session of Immuno-Oncology (IO) in ESMO24? A great presentation by Dr. Reuss on biomarkers analysis from neoadjuvant Immuno-Oncology: the role of STK11, KEAP1, and SMARCA4 could be very important for patient selection in the future. Also, PCR after neoadjuvant is still not enough for cure.”

Source: Edgardo S. Santos/X